![](/img/cover-not-exists.png)
THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysis
Chuang, Wan-Long, Hu, Tsung-Hui, Buggisch, Peter, Moreno, Christophe, Su, Wei-Wen, Biancone, Luigi, Hyland, Robert, Lu, Sophia, Markova, Svetlana, Dvory-Sobel, Hadas, Osinusi, Anu, Gaggar, Anuj, Peng,Volume:
70
Journal:
Journal of Hepatology
DOI:
10.1016/s0618-8278(19)30419-0
Date:
April, 2019
File:
PDF, 146 KB
2019